and the beneficial effects on cardiovascular risk, as evident from the cardiovascular outcomes trials (Fig
These medications mimic the naturally occurring GLP-1 hormone, which is produced by the small intestine
OMP continues to be converted into orotidine monophosphate (UMP) and then uridine triphosphate (UTP), which is then converted into CTP by cytidine triphosphate synthetase (CTPS) via utilizing the amide group on glutamine (Figure 1)
This effect directly opposes Wegovy's appetite-suppressing action, potentially reducing the caloric deficit necessary for weight loss
The findings point to a broader cardiometabolic and anti-inflammatory effect from the increasingly popular class of medications, which are commonly prescribed for diabetes, obesity and heart failure
Instead, the focus is on sustainable, healthy weight management that addresses the root causes of weight gain